Return On Equity of Medpace Holdings, Inc. from 30 Jun 2017 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Medpace Holdings, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2017 to 31 Dec 2025.
- Medpace Holdings, Inc. Return On Equity for the quarter ending 31 Dec 2025 was 119%, a 131% increase year-over-year.
- Medpace Holdings, Inc. annual Return On Equity for 2025 was 119%, a 131% increase from 2024.
- Medpace Holdings, Inc. annual Return On Equity for 2024 was 51%, a 20% decline from 2023.
- Medpace Holdings, Inc. annual Return On Equity for 2023 was 64%, a 5.9% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Medpace Holdings, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | 119% | +67% | +131% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | 92% | +41% | +81% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | 68% | +13% | +23% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | 54% | -5.4% | -9% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | 51% | -12% | -20% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | 51% | -18% | -26% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | 55% | -18% | -24% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | 60% | -15% | -21% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | 64% | +3.6% | +5.9% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | 68% | +27% | +65% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | 73% | +42% | +138% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | 75% | +51% | +211% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | 60% | +40% | +196% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | 41% | +20% | +93% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | 31% | +9.3% | +44% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | 24% | +4.2% | +21% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | 20% | +1.4% | +7.2% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | 21% | +4.7% | +28% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | 21% | +6.4% | +43% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | 20% | +4.2% | +27% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | 19% | +4.2% | +28% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | 17% | +2.2% | +15% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | 15% | +0.35% | +2.4% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | 16% | +2.4% | +18% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | 15% | +1.8% | +14% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | 15% | +3% | +26% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | 15% | +4.7% | +48% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | 13% | +5.1% | +62% | 01 Jan 2019 | 31 Mar 2019 |
| Q4 2018 | 13% | +6.3% | +92% | 01 Oct 2018 | 31 Dec 2018 |
| Q3 2018 | 12% | +6.9% | +147% | 01 Jul 2018 | 30 Sep 2018 |
| Q2 2018 | 9.8% | +6.1% | +161% | 01 Apr 2018 | 30 Jun 2018 |
| Q1 2018 | 8.2% | 01 Jan 2018 | 31 Mar 2018 | ||
| Q4 2017 | 6.8% | 01 Oct 2017 | 31 Dec 2017 | ||
| Q3 2017 | 4.7% | 01 Jul 2017 | 30 Sep 2017 | ||
| Q2 2017 | 3.8% | 01 Apr 2017 | 30 Jun 2017 |
Medpace Holdings, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | 119% | +67% | +131% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | 51% | -12% | -20% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | 64% | +3.6% | +5.9% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | 60% | +40% | +196% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | 20% | +1.4% | +7.2% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | 19% | +4.2% | +28% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | 15% | +1.8% | +14% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | 13% | +6.3% | +92% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | 6.8% | 01 Jan 2017 | 31 Dec 2017 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.